Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men

American Heart Journal

Volumn 139, Issue 1 I, 2000, Pages 164-173

  Bremner, W Fraser ^a,b,c,d,e,f   Sothern, Robert B ^a,b,c,d,e   Kanabrocki, Eugene L ^a,b,c,d,e   Ryan, May ^a,b,c,d,e   McCormick, James B ^a,b,c,d,e   Dawson, Susan ^a,b,c,d,e   Connors, Eileen S ^a,b,c,d,e   Rothschild, Renee ^a,b,c,d,e   Third, Jane L H C ^a,b,c,d,e   Vahed, Sabera ^a,b,c,d,e   Nemchausky, Bernard M ^a,b,c,d,e   Shirazi, Parvez ^a,b,c,d,e   Olwin, John H ^a,b,c,d,e  

^a MacNeal Cardiology Group   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Surgical Services Edward Hines Veterans Affairs Hospital   (United States)

^d SWEDISH COVENANT HOSPITAL   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f MacNeal Cardiology Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENVIRONMENTAL FACTOR; FIBRINOGEN BLOOD LEVEL; HEART DEATH; HEREDITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; THROMBOCYTE; TISSUE INJURY;

EID: 0033977130     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90324-7     Document Type: Article

References (75)

1. Bremner WF, Sothern RB, Kanabrocki EL, Ryan M, McCormick JB, Dawson S, et al. Circadian variations in serum lipoprotein-a in adult men [abstract]. Chronobiol Int 1997;14:23.
2. Kanabrocki EL, Hermida RC, Sothern RB, Dawson S, McCormick JB, Bremner WF, et al. Circadian aspects of serum cholesterol and aging. Chronobiol Int 1997;14:79.
3. Touitou Y, Haus E. Biologic rhythms in clinical and laboratory medicine. New York: Springer-Verlag; 1992.
4. Rivera-Coll A, Fuentes-Arderiu X, Diez-Noguera A. Circadian rhythmic variations in serum concentrations of clinically important lipids. Clin Chem 1994;40:1549-53.
5. Statland BE, Winkel P, Bokelund H. Factors contributing to intra-individual variation in serum constituents; 1: within-day variation of serum constituents in healthy subjects. Clin Chem 1973;19:1374-9.
6. Winkel P, Statland BE, Bokelund H. The effects of time of venipuncture on variation of serum constituents. Am J Clin Pathol 1975;64:433-7.
7. Panek E, Steinmetz J. The effect of sex, deviation from ideal weight and sampling time on blood constituents in presumably healthy subjects [abstract]. Clin Chim Acta 1979;92:343-51.
8. Kanabrocki EL, Sothern RB, Scheving LE, et al. Reference values for circadian rhythms of 98 variables in clinically healthy men in the fifth decade of life. Chronobiol Int 1990;7:445-61.
9. Miller M, Bachorik PS, Cloey TA. Normal variation of plasma lipoproteins: postural effects on plasma concentrations of lipids, lipoproteins, and apoproteins. Clin Chem 1992;38:569-74.
10. MACRA Lp Enzyme Immunoassay Kit: catalog number D306. Elkton, Md.: Terumo Medical Corporation Diagnostic Division.
11. Halberg F, Johnson EA, Nelson W, Runge W, Sothern RB. Autorhythmometry: procedures for physiologic self-measurement and their analysis. Physiol Teach 1972;1:1-11.
12. Mojón A, Fernandez JR, Hermida RC. Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. Chronobiol Int 1992;9:403-12.
13. Berg K. A new serum type system in man: the Lp(a) lipoprotein system. Acta Pathol Microbiol Scand 1963;59:369-82.
14. Scanu AM. Plasma lipoproteins: an overview. In: Scanu AM, Spector AA, editors. Biochemistry and biology of plasma lipoproteins. New York: Marcel Dekker; 1986.
15. Havel RJ, Kane JP. Structure and metabolism of plasma lipoproteins. In: Scriver CR, Beaudet AL, Sly WS, et al, editors. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill; 1989. p. 1129.
16. Breslow JL. Genetics of lipoprotein disorders. Circulation 1993;87 Suppl 3:16-21.
17. Fredrickson DS. Phenotyping: on reaching base camp (1950-1975). Circulation 1993;87 Suppl 3:1-15.
18. Scanu AM. Lipoprotein disorders as related to atherosclerotic cardiovascular disease. Surg Clin North Am 1995;75:557-67.
19. Curtiss LK, Plow EF. Interaction of plasma lipoproteins with human platelets. Blood 1984;64:365-74.
20. Miles LA, Plow EF. Binding and activation of plasminogen on the platelet surface. J Biol Chem 1985;260:4303-11.
21. Ezratty A, Simon DL, Loscalzo J. Lipoprotein binds to human platelets and attenuates plasminogen binding and activation. Biochemistry 1993;32:4628-33.
22. Scanu AM, Miles LA, Fless GM, Pfaffinger D, Eisenhart J, Jackson E, et al. Rhesus monkey lipoprotein binds to lysine sand U937 monocytoid cells less efficiently than human lipoprotein(a): evidence for the role of kringle 4. J Clin Invest 1993;44:283-91.
23. Scanu AM, Ofaffinger D, Lee JC, Hinman J. A single point mutation in human apo(a) kringle 4-37 associated with lysine binding defect in Lp(a). Biochim Biophys Acta 1994;1227:41-5.
24. Scanu AM, Edelstein C. Kringle-dependent structural and functional polymorphism of apolipoprotein(a). Biochim Biophys Acta 1995;1256:1-12.
25. Edelstein C, Italia JA, Klezovitch O, Scanu AM. Functional and metabolic differences between elastase-generated fragments of human lipoprotein(a) and apolipoprotein(a). J Lipid Res 1996;37:1786-801.
26. Klezovitch O, Edelstein C, Scanu AM. Evidence that the fibrinogen binding domain of apo(a) is outside the lysine binding site (LBS) of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes. J Clin Invest 1996;98:185-91.
27. Mooser V, Seabra MC, Abedin M, Landschultz KT, Marcovina S, Hobbs HH. Apolipoprotein(a) kringle 4-containing fragments in human urine: relationship to plasma levels of lipoprotein(a). J Clin Invest 1996;97:858-64.
28. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in the general population of middle aged men. Br Med J 1990;301:1248-51.
29. Scanu AM, Fless GM. Lipoprotein(a) heterogeneity and biological relevance. J Clin Invest 1990;85:1709-15.
30. Jauhiainen M, Koskinen P, Ehnhom C, et al. Lipoprotein(a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis 1991;89:59-67.
31. Srinivasan SR, Delaney GH, Jarpa RA, Webber LS, Berenson GS. Racial (black-white) differences in serum lipoprotein(a) distribution and its relation to parental myocardial infarction in children. Circulation 1991;84:160-7.
32. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 1991;325:373-81.
33. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson M. Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 1992;69:1251-4.
34. Pauletto P, Puato M, Caroli MG, Casiglia E, Munhambo AE, Cazzolato G, et al. Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study. Lancet 1996;348:784-8.
35. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Quinci GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981;38:51-61.
36. Delaney GH, Guyton JR, Attar M, Farmer JA, Kantz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74:758-65.
37. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
38. Rhoads GC, Delaney G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-4.
39. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-5.
40. Pearson T, Davidson L, Jenkins P, Rybicki B, Klag M, Thomas J. Lipoprotein(a) levels in blacks vs whites: marked differences in levels and correlations with other lipids [abstract]. Circulation 1990,82:475A.
41. Loscaizo J. Lipoprotein(a): a unique risk factor for atherothrombic disease. Arteriosclerosis 1990;10:672-9.
42. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990,36:20-3.
43. Genest J Jr, Jenner JL, McNamara JR, Ordovas JM, Silberman SIR, Wilson PWF, et al. Prevalence of lipoprotein (a) [Lp(a)] in coronary artery disease. Am J Cardiol 1991;67:1039-45.
44. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-9.
45. Gaw A. Lipoproteins and the risk of myocardial infarction [letter]. JAMA 1994;271:1077-8.
46. Ritter MM, Geiss HC, Richter WO, Schwandt P. Lipoproteins and the risk of myocardial infarction [letter]. JAMA 1994;271:1077.
47. Hoff HF, Beck GKJ, Skibinski CI Jurgens G, O'Neil J, Lytle B. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988;77:1238-44.
48. Casale G, Macelloni R. Circadian rhythms of lipidic fractions in elderly persons. Z Alternsforsch 1985;40:309-11.
49. Wasenius A, Stugaard M, Otterstad JE, Frøyshov D. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest 1990;50:635-42.
50. Maher VM, Brown BG. Lipoprotein(a) and coronary heart disease. Curr Opin Lipidol 1995;6:229-35.
51. Enholm C, Garoff H, Renkonen O, Simons K. Protein and carbohydrate composition of Lp(a) lipoproteins from human plasma. Biochemistry 1972;11:3229-37.
52. Fless GM, Trolih CA, Scanu AM. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem 1984;259:11470-8.
53. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
54. Stone MC, Thorp JM. Plasma fibrinogen: a major coronary risk factor. J R Coll Gen Pract 1985;291:1312-4.
55. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 1987;258:1183-6.
56. Smolensky MH, Halberg F, Sargent R. Chronobiology of the life sequence. In: Itoh S, Osata K, Yoshimura H. Advances in climatic physiology. Tokyo: Igaku Shoin; 1972. p. 281-318.
57. Balleisen L, Bailey J, Epping PH, Schutte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population; I: baseline data on the relation to age, gender, bodyweight, smoking, alcohol, pill-using, and menopause. Thromb Haemost 1985;54:475-9.
58. Muller JE, Ludmer PL, Willich N, Tofler GH, Aylmer G, Klangos I, et al. The MILIS Study Group: circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8.
59. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60:801-6.
60. Abdreatti F, Davies GH, Hackett DR, Khan MI, DeBart ACW, Aber VR, et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am J Cardiol 1988,62:635-7.
61. Imeson JD, Meade TW, Steward GM. Day by day variations in fibrinolytic activity and in mortality from ischemic heart disease. Int J Epidemiol 1987,16:626-7.
62. Beard CM, Fuster V, Elveback LR. Daily and seasonal variations in sudden cardiac death: Rochester, Minnesota, 1950-1975. Mayo Clin Proc 1982;57:704-61.
63. Gill JS, Davies P, Gill SK, Beevers DG. Wind-chill and seasonal variation of cerebrovascular disease. J Clin Epidemiol 1988;41:225-30.
64. Kanabrocki EL, Sothern RB, Bremner WF, Demakis JG, Bean JT, Ringelstein JG, et al. Weekly and yearly rhythms in plasma fibrinogen in hospitalized male military veterans. Am J Cardiol 1995;76:628-31.
65. Haus E, Lakatua DJ, Sackett-Lundeen LL, Swoyer J. Chronobiology in laboratory medicine. In: Rietveld WJ, editor. Clinical aspects of chronobiology. Leiden, The Netherlands: Hoechst Meducation Service, 1984. p. 13-83.
66. Jovicic A, Mandic S. Circadian variation of platelet aggregability and fibrinolytic activity in healthy subjects. Thromb Res 1991;62:65-74.
67. Jafri SM, VanRollins M, Ozawa T, Mammen EF, Goldberg AD, Goldstein S. Circadian variation in platelet function in healthy volunteers. Am J Cardiol 1992;69:951-4.
68. Nademanee K, Intrachot V, Josephson MA, Singh BN. Circadian variation in occurrence of transient overt and silent myocardial ischemia in chronic stable angina and comparison with prinzmetal angina in men. Am J Cardiol 1987;60:494-8.
69. Rocco MB, Barry J, Campbell S. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.
70. Hjalmarson A, Gilbin EA, Nicod P, Dittoich H, Henning H, Engler R, et al. Differing circadian patterns of symptoms onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267-75.
71. Toffler GE, Brezenski DA, Schafer AI, Cziesler CA, Rutherford JD, Willich SN, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-8.
72. Cannon CP, McCabe CH, Stone PH, Schactman M, Thompson B, Theroux P, et al. Circadian variation in the onset of unstable angina and non-Q-wave myocardial infarction. Am J Cardiol 1997;79:253-8.
73. Hayashi S, Toyoshima H, Tanabe N, Miyanishi K. Daily peaks in the incidence of sudden cardiac death and fatal stroke in Niigata Prefecture. Jpn Circ J 1996;60:193-200.
74. Sothern RB, Gruber SA. Further commentary: hysiological parameters in laboratory animals and humans. Pharm Res 1994;11:349-50.
75. Sothern RB. Time of day versus internal circadian timing references. J Infus Chemother 1995;5:24-30.